VivaQuant Inc.

VivaQuant Inc. has 2 AI-enabled medical devices on the FDA list. The first decision was on February 16, 2019 and the most recent on September 2, 2020 (RX-1 Rhythm Express Remote Cardiac Monitoring System). Its most common review panel is Cardiovascular (2 devices).